OB 318Alternative Names: OB-318
Latest Information Update: 26 Aug 2016
At a glance
- Originator Oneness Biotech
- Class Anti-inflammatories; Antineoplastics; Herbal medicines; Traditional-Chinese-medicine
- Mechanism of Action 1 Phosphatidylinositol 3 kinase inhibitors; MTOR protein inhibitors; Proto oncogene protein c-akt inhibitors; Vascular endothelial growth factor A inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Hepatocellular carcinoma